Development

Agnes Shanley is senior editor of Pharmaceutical Technology.

Articles

Successful development requires coordinating and aligning drug and device design, focusing on a complete drug delivery system that meets patients’ needs.

Taking a Systems Approach to Inhalation Therapy Development

Catalent combines its formulation expertise, manufacturing excellence and particle size reduction technologies to provide a broad range of solutions in the development of inhalation and nasal drug products.

Manufacturing and Formulation Solutions for Inhaled Dose Forms

The project will foster the translation of nanomedicine applications for the treatment of cardiovascular diseases.

Nemera Joins European Project to Develop Inhaled Nanoparticles for Heart Disease

The Intelligent Control Inhaler is an intuitive, fully-integrated device delivering accurate doses of medication to patients, while providing on-screen instructions for use and feedback to the patient and healthcare provider via an app.

3M’s Intelligent Inhaler Wins Excellence in Drug Delivery Devices Award at CPhI

Alex Slowey is Formulation Specialist at 3M Drug Delivery Systems Division, UK. Morley Street Loughborough Leicestershire LE11 1EP Tel. +44 (0)1509 613913 aslowey1@mmm.com

Understanding the components of a reference marketed pMDI is needed to develop a generic pMDI.

Reverse Engineering a Pressurized Metered Dose Inhaler

Successful drug delivery via a dry powder inhaler is determined by the API physicochemical properties, the formulation composition and process, the device and operating conditions, the patient–device relationship, the environmental variables, and ultimately, patient compliance.

Developing an Orally Inhaled Dry Powder Formulation—A Complex Itinerary and a Technological Challenge

Experts attending the European Psychiatry Association Congress in Vienna say that Adasuve has made an impact in the treatment of agitation in patients suffering from schizophrenia or biopolar I disorder.

Innovative Inhaled Antipsychotic Formulation Adasuve Provides Quick and Effective Treatment

Aptar Pharma has partnered with Shanghai Sine Promod Pharmaceutical to develop and launch its new budesonide dry powder inhaler (DPI), which features Aptar Pharma’s user-friendly and cost-effective Twister DPI.

Shanghai Sine Promod Pharmaceutical Chooses Aptar Pharma’s Twister DPI for Asthma Therapy

Sanofi launched a rapidly absorbed, short-acting inhalable insulin in the US to help control type 1 and type 2 diabetes.

First Inhalable Insulin Comes to the US

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Experts discuss factors affecting drug delivery to the lungs and key considerations when developing inhalation formulations.

Formulation and Drug Delivery, Inhalation Drugs